Patterson, Marc C.
Article History
First Online: 21 September 2016
Competing interests
: The author has received research support from Actelion Pharmaceuticals and Orphazyme (pending), and has consulted for Actelion, Amicus, Genzyme, Novartis, Orphazyme, Shire, Stem Cells and Vtesse.
Free to read: This content has been made available to all.